
table of contents
The rapidly changing regulatory environment and updates in clinical and basic research are impacting the cost structure and demand outlook for peripheral industries such as healthcare, food, nursing care, and addiction treatment. In particular, the expansion of legal states, new findings on hemp protein as a functional food ingredient, and implications for clinical side effect management (CHS) are issues that directly impact supply chain design and risk management for insurance and healthcare providers. Technical terms are explained and organized so that even junior high school students can understand.
概況
- Regulation and prevalenceAs of 2025, medical use will be legal in 39 states and recreational use in 24 states in the US. With more than half of the population under some form of legalization, operational assumptions in the medical, retail, and treatment fields will change.
- Clinical and Public Health: Seen in chronic usersCannabinoid Hyperemesis Syndrome (CHS)Case report: "Single alcohol consumption" may be a trigger. Risk of serious electrolyte abnormalities suggested.
- Market and product developmentHemp-derived protein hydrolysate (HPH) exhibits lipid-lowering activity and is attracting attention as a potential functional food ingredient. Its functional profile changes through synergistic processing with enzymes and microorganisms.
The concept of "preference and incentive design" in behavioral economics is also relevant to cannabis legalization and clinical explanations (CHS risk notification). Consumer and patient decisions are strongly influenced by the way information is presented and the environment (legality, price, access).
Regulation/Policy
In the United StatesMedical use in 39 states, recreational use in 24 states (as of 2025)As legalization progresses in the United States, how to handle "secondary cannabis use during treatment" in addiction treatment programs (especially for alcohol use disorder (AUD)) has become a new clinical and operational issue. This is expected to have an impact on treatment retention rates, insurance claims, and program design, and operators will need to revise their in-house policies and patient explanations (results data were not presented in this study).
(https://pubmed.ncbi.nlm.nih.gov/41764413/)
Glossary: Recreational and medical legalization refers to the rules established by each state regarding who can possess and use cannabis, for what purpose, and in what quantity. Even when legal, there are differences in alignment with federal law and local ordinances, making business practices complicated.
Markets and products (food tech and functional ingredients)
Derived from hemp (Cannabis sativa L.)Hemp Protein Hydrolysate (HPH)However, it has been shown to inhibit digestive enzymes and improve lipid metabolism in cell models. Enzyme treatment and fermentation alter the secondary and tertiary structure, with a decrease in alpha helix and an increase in beta sheet, which is associated with improved functionality.
| Evaluation item | Quantitative results |
|---|---|
| Pancreatic lipase inhibition (IC50) | 1.999 ± 0.142 mg/mL |
| Cholesterol esterase inhibition (IC50) | 3.046 ± 0.102 mg/mL |
| HepG2 cells Total cholesterol reduction | −39.71% |
| HepG2 cells triglyceride lowering | −30.84% |
| HepG2 cells LDL-C reduction | −21.94% |
| HepG2 cells HDL-C increase | x1.4 |
Activation of the AMPK pathway and regulation of SREBP1/PPARα/HMGCR/PCSK9-LDLR have been demonstrated, making it a candidate mechanism for improving lipid metabolism. This is likely to lead to further discussions on optimizing processing design (enzymes and microorganisms) for the development pipeline of functional food and supplement ingredients.
(https://pubmed.ncbi.nlm.nih.gov/41763749/)
Terminology: IC50 is the concentration required for half the effect. The smaller the IC50, the stronger the effect. AMPK is like an energy management switch in the body, and works to suppress fat synthesis.
Clinical and public health (cost and operational implications)
1. Cannabinoid Hyperemesis Syndrome (CHS) and Alcohol
Chronic cannabis usersCHSA case was reported in a 52-year-old man who experienced repeated episodes of hyponatremia approximately one week after a single alcohol intake. In the most recent episode, severe hyponatremia required ICU care, and the diagnosis was consistent with CHS, with other illnesses ruled out. While this is a case-by-case study, it has been suggested that confirming a patient's history of alcohol use during interviews may contribute to prevention and recurrence. Given the impact on emergency and hospitalization costs and bed occupancy, this is a topic for protocol review.
(https://pubmed.ncbi.nlm.nih.gov/41769444/)
Glossary: CHS is "periodic, severe nausea and abdominal pain that occurs in people who have been using cannabis for a long time." Unlike regular gastroenteritis, it is known to be temporarily relieved by a hot shower (no detailed information on the behavior of this case was provided).
2. Housing assistance programs and their use among young people (Boston area)
Young adults (mean age 21.2 years, n=104) participating in a rapid rehousing program in the Boston areaPast month cannabis use rate: 72.1%The success rate of housing after one year is64.4 %Among females at birth24.5% (13/53)became pregnant during the support period, and the person in question100 %experienced interpersonal violence during the intervention period. The coexistence of social vulnerability and substance use has implications for support design and expenditure allocation across housing, welfare, and medical care (detailed factors in multivariate logistic regression are partially omitted from the abstract).
(https://pubmed.ncbi.nlm.nih.gov/41770162/)
3. Cannabis use among caregivers (systematic review)
A review of five studies on elderly caregivers revealed that fourCaregivers with higher stress and emotional burden are more likely to use cannabisTwo studies found new or increased use during the COVID-19 pandemic.Improved self-reported health and well-being, in another studyFavorable attitudes toward recreational cannabisIn two studiesHigh anxiety and increased useThis is related to maintaining the health of care workers, preventing turnover, and designing employee benefits, but there is limited evidence regarding causal relationships and long-term outcomes.
(https://pubmed.ncbi.nlm.nih.gov/41767904/)
4. Complexity and frequency of use of EEG (basic research)
Prefrontal cortexMultiscale Entropy (MSE)This study examines the relationship between frequency of use and baseline differences between brain regions. It offers implications for setting research themes for corporate brain tech, safe driving support, and work aptitude assessment. However, at this stage, abstract information on the quantitative effects that could be used to determine clinical and business applications is limited.
(https://pubmed.ncbi.nlm.nih.gov/41768209/)
Glossary: Multiscale entropy (MSE) is an index that measures the "complexity of brain waves." A high or low value is thought to indicate a difference in the diversity of brain activity patterns (however, it is not an index that can be used to immediately determine a diagnosis).
5. Oxidative stress (preclinical meta-analysis)
Cannabis-induced oxidative stressIntegrating preclinical evidenceThis meta-analysis is attracting attention as a source of basic knowledge related to toxicity and safety assessment, occupational health and safety, and insurance underwriting. However, the feasibility of clinical application (in humans) needs to be verified separately.
(https://pubmed.ncbi.nlm.nih.gov/41765278/)
6. Glioblastoma and Receptors (Review)
We summarize the expression of nuclear and membrane receptors in brain tumors (glioblastoma) and their therapeutic implications.Cannabinoid ReceptorsIt has also been suggested that it is involved in tumor growth and drug response, and there is academic interest in exploring its drug targets. Understanding its network with androgen receptors and GPCRs (e.g., CXCR4, membrane estrogen receptors) is important.
(https://pubmed.ncbi.nlm.nih.gov/41768124/)
7. Dental regenerative medicine and CBD (scoping review)
CBDThe effects of on osteoblast and odontoblast differentiation of human dental pulp stem cells (hDPSCs) were mapped in vitro. This suggests future implications for the dental regenerative medicine and biomaterials market. However, further research is needed to determine clinical applicability and dosage.
(https://pubmed.ncbi.nlm.nih.gov/41767216/)
Today's three highlights
- Expanding legal states in the USpresents new challenges for addiction treatment management, with protocols designed to address secondary cannabis use during treatment becoming key.
- Single alcohol ingestion as a new potential trigger for CHSreported that medical interviews and education are important in practice to avoid the spread of emergency and hospitalization costs.
- Hemp Protein HydrolysateIt has the potential to be a functional ingredient due to its lipid-improving effect. Optimizing the processing process is the key to product differentiation.
Collection List
- Predictors of 1-year housing outcomes among young adults experiencing homelessness enrolled in a rapid rehousing program (https://pubmed.ncbi.nlm.nih.gov/41770162/)
- Alcohol as a Novel Trigger for Cannabis Hyperemesis Syndrome (https://pubmed.ncbi.nlm.nih.gov/41769444/)
- Regional and cannabis-related differences in prefrontal multiscale entropy of resting-state EEG (https://pubmed.ncbi.nlm.nih.gov/41768209/)
- Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implications (https://pubmed.ncbi.nlm.nih.gov/41768124/)
- Cannabis Use Among Caregivers of Older Adults: A Systematic Literature Review (https://pubmed.ncbi.nlm.nih.gov/41767904/)
- Bioactivity and Regenerative Potential of Cannabidiol in Human Dental Pulp Stem Cells: A Scoping Review of In Vitro Studies (https://pubmed.ncbi.nlm.nih.gov/41767216/)
- Preclinical Evidence of Cannabis-Induced Oxidative Stress: A Systematic Review and Meta-Analysis (https://pubmed.ncbi.nlm.nih.gov/41765278/)
- Investigating the Effect of Secondary Cannabis Use in Treatment Discontinuation Among Individuals Undergoing Alcohol Use Disorder Treatment (https://pubmed.ncbi.nlm.nih.gov/41764413/)
- Structural characterization, physicochemical properties and hypolipidemic activity of hemp (Cannabis sativa L.) protein hydrolysates prepared via enzyme-microbial synergy(https://pubmed.ncbi.nlm.nih.gov/41763749/)

![Mail-order product: MDMA × MM Analog [For Research Use]](https://www.thch-vape.shop/html/user_data/assets/img/products/213_250x250.webp)


